Onkologie, Hämatologie - Daten und Informationen

9 Tumorlysesyndrom - Prophylaxe und Therapie: Literatur

Autor/en: M. Sökler, H. Ostermann, C. Bokemeyer
Letzte Änderung: 18.06.2012
  • Agha-Razii M, Amyot SL, Pichette V, Cardinal J, Ouimet D, Leblanc M.
    Continuous veno-venous hemodiafiltration for the treatment of spontaneous tumor lysis syndrome complicated by acute renal failure and severe hyperuricemia.
    Clinical Nephrol 2000;54:59-63. PMID:10939758

  • Altman A.
    Acute Tumor lysis syndrome.
    Semin Oncol 2001;28:3-8. PMID:11343271

  • Annemans L, Moeremans K, Lamotte M, Garcia Conde J, Berg H, Myint H, Pieters R, Uyttebroeck A.
    Pan-European multicentre economic evaluation of recombinant urate oxidase (rasburicase) in prevention and treatment of hyperuricaemia and tumour lysis syndrome in haematological cancer patients.
    Support Cancer Care 2003a;11:249-257. PMID:12673464

  • Annemans L, Moeremans K, Lamotte M, Garcia Conde J, Van Den Berg H, Myint H, Pieters R, Uyttebroeck A.
    Incidence, medical resource utilisation and costs of hyperuricemia and tumour lysis syndrome in patients with acute leukaemia and non-Hodgkin´s lymphoma in four European countries.
    Leuk Lymphoma 2003b;44:77-83. PMID:12691145

  • Arrambide K, Toto RD.
    Tumor lysis syndrome.
    Semin Nephrol 1993;13:273-280. PMID:8321927

  • Baeksgaard L, Sorensen JB.
    Acute tumor lysis syndrome in solid tumors - a case report and review of the literature.
    Cancer Chemother Pharmacol 2003;51:187-192. PMID:12655435

  • Beriwal S, Singh S, Garcia-Young JA.
    Tumor lysis syndrome in extensive-stage small-cell lung cancer.
    Am J Clin Oncol 2002;25:474-475. PMID:12393987

  • Bosly A, Sonet A, Pinkerton CR, McCowage G, Bron D, Sanz MA, Van den Berg H.
    Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer.
    Cancer 2003;98:1048-1054. PMID:12942574

  • Cairo MS, Bishop M.
    Tumour lysis syndrome: new therapeutic strategies and classification
    Br J Haematol 2004;127:3-11. PMID:15384972

  • Cairo MS, Coiffier B, ReiterA, Younes A, on behalf of the TLS expert panel.
    Recommendatipns for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus.
    British J Haematol 2010;149 :578-586. PMID:20331465

  • Cany L, Fitoussi O, Boiron JM, Marit G.
    Tumor lysis syndrome at the beginning of thalidomide therapy for multiple myeloma.
    J Clin Oncol 2002;20:2212. PMID:11956286

  • Cohen LF, Ballow JE, Magrath IT et al.
    Acute tumor lysis syndrome: A review of 37 patients with Burkitt’s lymphoma.
    Am J Med 1980;68:486-491. PMID:7369230

  • Coiffier B, Riouffol C.
    Management of tumor lysis syndrome in adults.
    Expert Rev Anticancer Ther 2007;7:233-239. PMID:17288532

  • Coiffier B, Mounier N, Bologna S, Fermé C, Tilly H, Sonet A, Christian B, Casasnovas O, Jourdan E, Belhadj K, Herbrecht R.
    Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin’s lymphoma: results of the GRAAL1(Groupe d’etude des lymphomes de l’adulte trial on rasburicase activity in adult lymphoma) study.
    J Clin Oncol 2003;21:4402-4406. PMID:14581437

  • Cortes J, Moore JO, Maziarz RT, Wetzler M, Craig M, Matous J, Luger S, Dey BR, Schiller GJ, Pham D, Abboud CN, Krishnamurthy M, Brown Jr A, Laadem A, Seiter K.
    Control of Plasma Uric Acid in Adults at Risk for Tumor Lysis Syndrome: Efficacy and Safety of Rasburicase Alone and Rasburicase Followed by Allopurinol Compared with Allopurinol Alone - Results of a Multicenter Phase III Study.
    J Clin Oncol 2010;28:4207-4213. PMID:20713865

  • Fassas AB, Desikan KR, Siegel D, Golper TA, Munshi NC, Barlogie B, Tricot G.
    Tumour lysis syndrome complicating high-dose treatment in patients with multiple myeloma.
    Br J Haematol 1999;105:938-941. PMID:10554803

  • Flombaum CD.
    Metabolic emergencies in the cancer patient.
    Semin Oncol 2000;27:322-334. PMID:10864220

  • Goldman SC, Holcenberg JS, Finklestein JZ, Hutchinson R, Kreissman S, Johnson FL, Tou C, Harvey E, Morris E, Cairo MS.
    A randomised comparison between rasburicase and allopurinol in children with lymphoma or leukaemia at high risk for tumor lysis.
    Blood 2001;97:2998-3003. PMID:11342423

  • Hain RD, Rayner L, Weitzman S, Lorenzana A.
    Acute tumour lysis syndrome complicating treatment of stage IVS neuroblastoma in infants under six months old.
    Med Pediatr Oncol 1994;23:136-139. PMID:8202037

  • Hande KR, Garrow GC.
    Acute tumor lysis syndrome in patients with high-grade non-Hodgkins’s lymphoma.
    Am J Med 1993;4:133-139. PMID:8430709

  • Hochberg J, Cairo MS.
    Tumor lysis syndrome: current perspective
    Haematologica 2008;93(1):9-13. PMID:18166779

  • Howard SC, Jones DP, Pui CH.
    The tumor Lysis Syndrome
    N Engl J Med 2011;364:1844-1854. PMID:21561350

  • Hummel M, Buchheidt D, Reiter S, Bergmann J, Hofheinz R, Hehlmann R.
    Successful treatment of hyperuricemia with low doses of recombinant urate oxidase in four patients with hematologic malignancy and tumor lysis syndrome.
    Leukemia 2003;17:2542-2544. PMID:14523460

  • Hummel M, Reiter S, Adam K, Hehlmann R. Buchheidt D
    Effectivel treatment and prophylaxis of hyperuricemia and impaired renal function in tumor lysis syndrome with low doses of rasburicase.
    Europ J Haematol 2008; 80:331-6. PMID:18081720

  • Hussain K, Mazza JJ, Clouse LH.
    Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): case report and review of the literature.
    Am J Hematol 2003;72:212-215. PMID:12605395

  • Jeha S.
    Tumor lysis syndrome.
    Semin Hematol 2001;38:4-8. PMID:11694945

  • Jones DP, Mahmoud H, Chesney RW.
    Tumor lysis syndrome: pathogenesis and management.
    Pediatr Nephrol 1995;9:206-212. PMID:7794722

  • Kelton J, Kelley WN, Holmes EW.
    A rapid method for the diagnosis of acute uric acid nephropathy.
    Arch Intern Med 1978;138:612-615. PMID:637642

  • Kjellstrand CM, Campell DC, von Hartitzsch B, Buselmeier TJ.
    Hyperuricemic acute renal failure.
    Arch Intern Med 1974;133:349-359. PMID:4283735

  • Krych M, Dreyling M, Kneba M, Hoelzer D, Hiddemann W, Hallek M.
    Prophylaxe und Therapie des Tumorlysesyndroms.
    Dtsch Med Wochenschr 2004;129:1440-1445. PMID:15213877

  • Lim EM, Bennett P, Beilby J.
    Sample preparation in patients receiving uric acid oxidase (rasburicase) therapy.
    Clinical Chemistry 2003;49:1417-1419. PMID:12881465

  • Linck D, Basara N, Tran V, Vucinic V, Hermann S, Hoelzer D, Fauser AA.
    Peracute onset of severe tumor lysis syndrome immediately after 4 Gy fractionated TBI as part of reduced intensity preparative regimen in a patient with T-ALL with high tumor burden.
    Bone Marrow Transplantation 2003;31:935-937. PMID:12748673

  • McDonnell AM, Lenz KL, Frei-Lahr DA, Hayslip J, Hall PD.
    Single-dose rasburicase 6 mg in the management of tumor lysis syndrome in adults.
    Pharmacotherapy. 2006;26:806-812. PMID:16716134

  • Mahajan A, Nirmal S, English MW, Jenney ME, Lazda.
    Acute tumor lysis syndrome in Hodgkin disease.
    Med Pediatr Oncol 2002;39:69-70. PMID:12116088

  • Montesinos P, Lorenzo I, Martin G, Sanz J, Perez-Sirvent ML, Martinez D, Orti G, Algarra L, Martinez J, Moscardo F, de la Rubia J, Jarque I, Sanz G, Sanz MA
    Tumor lysis syndrome in patients with acute myeloid leukaemia: identification of risk factors and development of a predicitive model.
    Haematologica 2008;93:67-74. PMID:18166787

  • Navolanic PM, Pui CH, Larson RA, Bishop MR, Pearce TE, Cairo MS, Goldman SC, Jeha SC, Shanholtz CB, Leonard JP, McCubrey JA. Elitek TM.
    Rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a meeting report, Dallas, Texas, January 2002.
    Leukemia 2003;17:499-514. PMID:12646938

  • Patte C, Sakiroglu C, Ansoborlo S, Baruchel A, Plouvier E, Pacquement H, Babin-Boilletot A.
    Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d’Oncologie Pédiatrique LMB89 protocol.
    Ann Oncol 2002;13:789-795. PMID:12075750

  • Pentheroudakis G, O’Neill VJ, Vasey P, Kaye SB.
    Spontaneous acute tumor lysis syndrome in patients with metastatic germ cell tumours.
    Report of two cases.
    Support Care Cancer 2001;9:554-557. PMID:11680837

  • Pui CH.
    Urate oxidase in the prophylaxis or treatment of hyperuricemia: The United States experience.
    Semin Hematol 2001a;38:13-21. PMID:11694947

  • Pui CH, Jeha S, Irwin D, Camitta B.
    Recombinant urate oxidase (rasburicase) in the prevention and treatment of malignancy-associated hyperuricemia in pediatric and adult patients: results of a campassionate-use trial.
    Leukemia 2001b;15:1505-1509. PMID:11587206

  • Rostom AY, El-Hussainy G, Kandil A, Allam A.
    Tumor lysis syndrome following hemi-body irradiation for metastatic breast cancer.
    Ann Oncol 2000;11:1349-1351. PMID:11106126

  • Sallan S.
    Management of acute tumor lysis syndrome.
    Semin Oncol 2001;28:9-12. PMID:11343272

  • Sile S, Wall BM.
    Acute renal failure secondary to spontaneous acute tumor lysis syndrome in myelofibrosis.
    Am J Kidney Dis 2001;38:1-4. PMID:11576908

  • Tiu RV, Mountantonakis SE, Dunbar AJ, Schreiber MJ.
    Tumor lysis syndrome.
    Semin Thromb Hemostasis 2007;33:397-407. PMID:17525897

  • Trifilio S, Gordon L, Singhal S, Tallman M, Evens A, Rashid K, Fishman M, Masino K, Pi J, Mehta J.
    Reduced-dose rasburicase (recombinant xanthine oxidase) in adult cancer patients with
    Bone Marrow Transplantation 2006;37:997-1001. PMID:16708061

  • Tsokos GC, Balow JE, Spiegel RJ, Magrath IT.
    Renal and metabolic complications of undifferentiated and lymphoblastic lymphomas.
    Medicine 1981;60:218-229. PMID:6894477

  • Vadhan-Raj S, Fayad LE, Fanale MA, Pro B, Rodriguez A, Hagemeister FB, Bueso-Ramos CE, Zhou X, McLaughlin PW, Fowler N, Shah J, Orlowski RZ, Samaniego F, Wang M, Cortes JE, Younes A, Kwak LW, Sarlis NJ, Romaguera JE.
    A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome.
    Ann Oncol 2011; doi:10.1093/annonc/mdr490
    [Abstract online]

  • Wössmann W, Schrappe M, Meyer U, Zimmermann M, Reiter A.
    Incidence of tumor lysis syndrome in children with advanced stage Burkitt´s lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase.
    Ann Hematol 2003;82:160-165. PMID:12634948

  • Yang H, Rosove MH, Figlin RA.
    Tumor lysis syndrome occurring after the administration of rituximab in lymphoproliferative disorders: high-grade non-Hodgkins-s lymphoma and chronic lymphocytic leukaemia.
    Am J Hematol 1999;62:247-250. PMID:10589082

  • Yang SS, Chau T, Dai MS, Lin SH.
    Steroid-induced tumor lysis syndrome in a patient with preleukemia.
    Clin Nephrol 2003;59:201-205. PMID:12653264

  • Yim BT, Sims-Mccallum P, Chong PH.
    Rasburicase for the treatment and prevention of hyperuricemia.
    Ann Pharmacother 2003;37:1047-1054. PMID:12841818

Arbeitsgemeinschaft Supportive Maßnahmen in der Onkologie, Rehabilitation u. Sozialmedizin d. Deutschen Krebsgesellschaft e.V. [Mehr]
Nach wie vor online verfügbar: die noch nicht aktualisierten Kapitel des Buches "Supportiv- therapie bei malignen Erkrank- ungen", bei ONKODIN publiziert in Kooperation mit "Deutscher Ärzte-Verlag", 2006. [Mehr]
Aktuelle Berichte vom 58th
ASH Annual Meeting 2016,
San Diego, Kalifornien, USA [Mehr]
2016 ASCO Annual Meeting - aktuelle Berichte. Dieser Service wird gefördert durch: